Loading clinical trials...
Loading clinical trials...
This study will evaluate the efficacy and safety of MYOBLOC in the treatment of Sialorrhea (drooling), which can be a symptom of many disease conditions. MYOBLOC will be injected directly into the sal...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Supernus Pharmaceuticals, Inc.
NCT07070817 · Sialorrhea True Bulbar Palsy Medullary Injury
NCT07158359 · Hypersialorrhea (Excessive Salivation), Psychiatric Disorders
NCT06101160 · Sialorrhea
NCT03747536 · Sialorrhea
NCT02382198 · Sialorrhea, Parkinson's Disease
Loma Linda, California
Los Angeles, California
National City, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions